These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16091933)

  • 1. Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1beta, TNF-alpha, and NO in vitro.
    Yao Z; Qiu S; Wang L; Lu R; Zhou CL; Zhao PP; Li HQ; Gao WY
    Cancer Immunol Immunother; 2006 Jan; 55(1):56-60. PubMed ID: 16091933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
    Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
    Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide(YSL).
    Lu R; Jia J; Bao L; Fu Z; Li G; Wang S; Wang Z; Jin M; Gao W; Yao Z
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):248-56. PubMed ID: 16028100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay.
    Li XL; Liu JY; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Jia J; Fu Z; Yao Z
    Invest New Drugs; 2008 Dec; 26(6):525-9. PubMed ID: 18264678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma.
    Wang C; Wang S; Lu R; Zhao L; Zhu ZF; Xu Q; Lv JQ; Wang LL; Fu Z; Lin G; Yao Z
    Anticancer Drugs; 2009 Aug; 20(7):534-42. PubMed ID: 19491661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma.
    Yao Z; Lu R; Jia J; Zhao P; Yang J; Zheng M; Lu J; Jin M; Yang H; Gao W
    Peptides; 2006 Jun; 27(6):1167-72. PubMed ID: 16129512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme).
    Kim YM; Talanian RV; Li J; Billiar TR
    J Immunol; 1998 Oct; 161(8):4122-8. PubMed ID: 9780184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of TNF-alpha, IL-1beta and nitrite release from mouse cultured spleen cells and lavaged peritoneal cells by mastoparan M.
    Wu TM; Chou TC; Ding YA; Li ML
    Immunol Cell Biol; 1999 Dec; 77(6):476-82. PubMed ID: 10571667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.
    Jia JB; Wang WQ; Sun HC; Liu L; Zhu XD; Kong LQ; Chai ZT; Zhang W; Zhang JB; Xu HX; Zeng ZC; Wu WZ; Wang L; Tang ZY
    Invest New Drugs; 2011 Oct; 29(5):861-72. PubMed ID: 20414698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway.
    Biswas SK; Sodhi A
    J Interferon Cytokine Res; 2002 May; 22(5):527-38. PubMed ID: 12060491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin.
    Qureshi AA; Tan X; Reis JC; Badr MZ; Papasian CJ; Morrison DC; Qureshi N
    Lipids Health Dis; 2011 Dec; 10():239. PubMed ID: 22185406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens.
    Chelvarajan RL; Collins SM; Doubinskaia IE; Goes S; Van Willigen J; Flanagan D; De Villiers WJ; Bryson JS; Bondada S
    J Leukoc Biol; 2004 Jun; 75(6):982-94. PubMed ID: 14982942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor.
    Qureshi AA; Guan XQ; Reis JC; Papasian CJ; Jabre S; Morrison DC; Qureshi N
    Lipids Health Dis; 2012 Jul; 11():76. PubMed ID: 22698256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines.
    Srividya S; Roy RP; Basu SK; Mukhopadhyay A
    J Leukoc Biol; 2000 May; 67(5):683-90. PubMed ID: 10811009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7.
    Kim JS; Kim KD; Na HS; Jeong SY; Park HR; Kim S; Chung J
    Mol Oral Microbiol; 2012 Jun; 27(3):149-59. PubMed ID: 22520385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation.
    Zhu ZF; Chen LJ; Lu R; Jia J; Liang Y; Xu Q; Zhou CL; Wang L; Wang S; Yao Z
    BMC Cancer; 2008 Nov; 8():342. PubMed ID: 19025669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Babesia bovis-stimulated macrophages express interleukin-1beta, interleukin-12, tumor necrosis factor alpha, and nitric oxide and inhibit parasite replication in vitro.
    Shoda LK; Palmer GH; Florin-Christensen J; Florin-Christensen M; Godson DL; Brown WC
    Infect Immun; 2000 Sep; 68(9):5139-45. PubMed ID: 10948137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory potential of pyocyanin in LPS-stimulated murine macrophages.
    Marreiro de Sales-Neto J; Lima ÉA; Cavalcante-Silva LHA; Vasconcelos U; Rodrigues-Mascarenhas S
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):102-108. PubMed ID: 30623710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.